AI Tool Comparison
Comparing as AI Computer Vision & Speech APIsD-ID vs Nabla
D-ID
VS
Nabla
Verdict by Category
Detailed Comparison
Feature
D-ID
Nabla
Pricing
FreemiumStudio Pricing:
Trial: $0 for 14 days, includes 3 minutes.
Lite: $4.7/month (billed annually at $56) for 10 min/month.
Pro: $16/month (billed annually at $191) for 15 min/month.
Advanced: $108/month (billed annually at $1,293) for 100 min/month.
Enterprise: Custom pricing.
API Pricing:
Trial: $0 for 14 days, up to 3 min video, 10 min streaming.
Build: $14.4/month (billed annually at $172.8) for 16 min video, 32 min streaming.
Launch: $35/month (billed annually at $420) for 45 min video, 90 min streaming.
Scale: $138.6/month (billed annually at $1,663.2) for 200 min video, 400 min streaming.
Enterprise: Custom pricing.
FreemiumNabla does not publish exact pricing on its official website; the primary calls-to-action are a free trial (via app.nabla.com) and "Talk to our team" for enterprise sales. Third-party sources consistently report a free tier with usage limits, with paid individual/clinician plans starting around $119/month per provider and higher tiers reported near $239/month per provider. Larger health-system deployments — Nabla's core market, spanning 130+ organizations — are sold via custom enterprise contracts with volume-based pricing, with independent estimates placing typical enterprise rates in the $150-$400/month per provider range depending on scale, EHR integration depth, and features. Exact costs require a sales conversation with Nabla.
Categories
AI Video ToolsAI Marketing ToolsAI ChatbotsAI Developer APIs & PlatformsAI Art & Animation ToolsAI Audio & Music Tools
AI Healthcare ToolsAI Productivity ToolsAI Developer APIs & Platforms
Summary
Create AI-powered videos and interactive visual AI agents
Ambient AI that turns patient visits into clinical notes, dictation, and coding — right inside the EHR
D-ID Pros & Cons
Pros
- Creates professional, scalable video content without traditional production.
- Offers diverse AI avatars, including custom and personal options.
- Supports multilingual video translation and localization with voice cloning.
- Enables interactive experiences with real-time visual AI agents.
- Provides API for seamless integration into existing workflows.
- Suitable for various business functions like marketing, sales, and training.
Cons
- Free trial includes a full-screen watermark on generated videos.
- Voice cloning is limited to higher-tier plans (Pro, Advanced, Enterprise).
- "Unlimited videos" in some plans are subject to reasonable use limits and a fair-use policy.
- Highest quality "Studio Avatars" are not included in lower-tier plans.
- Advanced features like team collaboration and professional services are exclusive to Enterprise plans.
- Credit-based system might require careful usage monitoring to avoid overages.
Nabla Pros & Cons
Pros
- Fast note generation, roughly five seconds, that closely mirrors real clinical documentation in independent tests
- Deep native integration with Epic and other major EHRs rather than copy-paste workflows
- Broad specialty and language coverage suited to large, diverse health systems
- Strong compliance posture (HIPAA, SOC 2 Type 2, ISO 27001, GDPR) with configurable data retention
- Backed by peer-reviewed evidence, including a NEJM AI randomized trial showing documentation-time reductions
- Combines documentation, dictation, and coding in one platform instead of separate point tools
Cons
- Pricing isn't published; individuals and smaller practices must go through a sales conversation or rely on third-party estimates to budget
- Primarily built for hospitals and health systems, so solo clinicians and small practices may find it less tailored than SMB-focused scribes
- Relies on ambient recording, so encounters where a patient or clinician can't or won't be recorded aren't well supported
- Some independent reviews note limited customization and quality drop-off on complex, multi-problem visits
- Mobile app store ratings are mixed and based on a relatively small number of reviews compared to the platform's overall clinician base